Published in
Taylor and Francis Group, Expert Opinion on Investigational Drugs, 1(28), p. 93-97, 2018
DOI: 10.1080/13543784.2019.1552677
Links
Tools
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease
Journal article published in 2018 by
Antoni Camins,
Miren Ettcheto 
,
Oriol Busquets,
Patricia R. Manzine,
Rubén Dario Castro-Torres,
Carlos Beas-Zarate,
Ester Verdaguer,
Francesc X. Sureda ,
Monica Bulló,
Jordi Olloquequi,
Carme Auladell,
Jaume Folch
,
Oriol Busquets,
Patricia R. Manzine,
Rubén Dario Castro-Torres,
Carlos Beas-Zarate,
Ester Verdaguer,
Francesc X. Sureda ,
Monica Bulló,
Jordi Olloquequi,
Carme Auladell,
Jaume Folch
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 